Medical device tax talk from both sides of the issue continued to grow louder this week as the House passed a bill in favor of repeal. Rhetoric ran wild, however, as seemingly everyone felt the need to weigh in on the issue before it hits the Democrat-dominated Senate, where it is expected to face much heavier opposition. In other news, The Atlantic examines the down side of the digital revolution in healthcare and MPMN previews possible changes on the horizon to ISO 10993 standards on biocompatibility regarding animal testing. Read about these issues and more in our weekly roundup below.

• Why a Vote on the Medical Device Excise Tax is the Biggest Deal Ever for Obamacare (Forbes)
• Could a Device Tax Repeal Spell the End for the Affordable Care Act? (MD+DI)
• Rep. Paulsen on Bringing the Medtech Tax Repeal to a Vote (MassDevice)
• Are Computers Getting Between You and Your Doctor? (The Atlantic)
• Alternatives to Animal Testing: Change Could Be on the Horizon for ISO 10993 (MPMN)
• FDA's Role in Regulating Mobile Medical Apps? (MedCity News)
• Italy Earthquakes Shake Local Medical Device Industry (medtechinsider)
• Sensor Initiative Supports Medtronic Diabetes in the Quest for the Artificial Pancreas (MPMN)